The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Trading Update

13 Dec 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Trading Update 13-Dec-2023 / 07:00 GMT/BST


Trading Update - Another Record Year of Growth

Acquisitions in London, Edinburgh and Amsterdam during 2023

Pipeline of 834 rooms due to open across the UK in 2024 including fifth hotel in London

ISE: DHG              LSE: DAL

 

Dublin and London | 13 December 2023:  Dalata Hotel Group Plc (“Dalata” or “the Group”), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, provides a trading update for the second half of 2023.

The Group continues to deliver an exceptional performance through strong trading and sustained growth. Hotel revenuei for the year 2023 is expected to exceed €600 million (2022: €516 million) and Adjusted EBITDA[i] for the year is expected to be in excess of €220 million (2022: €183 million). For the second half of 2023, Group RevPAR[ii] is expected to be 3% ahead of 2022 levels.

Operations have successfully commenced at the three hotels added to the portfolio during 2023 namely Maldron Hotel Finsbury Park, Clayton Hotel London Wall and Clayton Hotel Amsterdam American. The Group is pleased with the performance delivered to date at each of these hotels.

The Group looks forward to the completion of four new hotels during 2024, with its first hotel in both Brighton and Liverpool, its fourth hotel in Manchester and its fifth hotel in London. This will add 834 rooms to the portfolio. Development works are progressing well and the hotels are on track to open in mid-2024.

The Group is optimistic in its outlook for 2024 with strong lead indicators across our customer segments, including the return of more direct flight connections and the anticipated further recovery in corporate travel.

 

Dermot Crowley, CEO, Dalata said:

“Dalata is on course to deliver another exceptional result this year driven by strong operational performance across our existing hotels and the impact of new additions to the portfolio. This is a testament to the hard work, professionalism and dedication of all our people across our hotels and central office.

In our recent first-half results, we set out our firepower potential of €750 million to grow in the medium term beyond our currently announced pipeline. Since then, we have secured our second hotel in continental Europe with the addition of the newly rebranded Clayton Hotel Amsterdam American and the acquisition of our first site in Edinburgh where we will develop a four-star Clayton Hotel.

Our growth ambitions, coupled with strong demand across our markets and our financial capacity to secure attractive opportunities underscores our ongoing ability to deliver value to our shareholders.”

-ENDS-

 

 

About Dalata

Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014. Dalata is Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group’s portfolio comprises 53 three and four-star hotels with 11,412 rooms and a pipeline of over 1,300 rooms. The Group currently has 31 owned hotels, 19 leased hotels and three management contracts. Dalata successfully operates Ireland’s two largest hotel brands, the Clayton and the Maldron Hotels. For the six month period ended 30 June 2023, Dalata reported revenue of €284.8 million and a profit after tax of €42.0 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Carol Phelan, CFO

 Niamh Carr, Head of Investor Relations and Strategic Forecasting

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

 


[i] Refer to the Supplementary Financial Information within the Group’s results announcement for the six months ended 30 June 2023 for definitions

[ii] RevPAR is stated on a ‘like for like’ basis and excludes the performance of hotels that newly opened or ceased trading under the Group during the comparative years. For newly acquired, previously operating hotels, where pre-acquisition RevPAR data is available, these hotels are included on a ‘like for like’ basis.


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:TST
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:291536
EQS News ID:1795499
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
23rd Oct 201910:27 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSDirectorate Change
4th Oct 20199:47 amRNSHolding(s) in Company
3rd Oct 20194:25 pmRNSHolding(s) in Company
3rd Oct 20194:03 pmRNSHolding(s) in Company
3rd Oct 20192:30 pmRNSDirector/PDMR Shareholding
1st Oct 20191:33 pmRNSTotal Voting Rights
4th Sep 20192:59 pmRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirector/PDMR Shareholding
3rd Sep 20191:05 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSHalf-year Report
2nd Sep 20192:23 pmRNSTotal Voting Rights
29th Aug 20193:45 pmRNSHolding(s) in Company
23rd Aug 20198:55 amRNSDirector Declaration
1st Aug 20199:16 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSNotice of Results
11th Jul 20195:35 pmRNSHolding(s) in Company
10th Jul 201910:33 amRNSHolding(s) in Company
4th Jul 201910:57 amRNSBlock listing Interim Review
4th Jul 20199:44 amRNSHolding(s) in Company
1st Jul 20199:11 amRNSTotal Voting Rights
21st Jun 20197:00 amRNSEuronext Dublin Market Notice
20th Jun 20199:00 amRNSBlock listing application
4th Jun 20199:08 amRNSTotal Voting Rights
31st May 201910:05 amRNSHolding(s) in Company
2nd May 20194:54 pmRNSResult of AGM
2nd May 20197:00 amRNSAGM Statement
1st May 201910:01 amRNSTotal Voting Rights
10th Apr 20194:33 pmRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSEuronext Dublin Market Notice
5th Apr 201910:21 amRNSAdditional Listing
1st Apr 20194:39 pmRNSNotice of AGM
1st Apr 201910:21 amRNSTotal Voting Rights
21st Mar 20192:37 pmRNSAnnual Financial Report
20th Mar 201912:19 pmRNSHolding(s) in Company
19th Mar 201911:41 amRNSHolding(s) in Company
11th Mar 20191:05 pmRNSDirector/PDMR Shareholding - Replacement
11th Mar 201911:41 amRNSDirector/PDMR Shareholding
6th Mar 201910:57 amRNSHolding(s) in Company
4th Mar 201911:24 amRNSHolding(s) in Company
1st Mar 20198:47 amRNSTotal Voting Rights
26th Feb 20197:00 amRNSFinal Results
12th Feb 20193:59 pmRNSHolding(s) in Company
1st Feb 20199:10 amRNSTotal Voting Rights
21st Jan 20197:00 amRNSAcquisition
8th Jan 201910:45 amRNSNotice of Results
7th Jan 20194:29 pmRNSBlock listing Interim Review
3rd Jan 201912:24 pmRNSAcquisition
2nd Jan 201912:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.